HISTOACRYL: A Study of Its Efficacy in Final Scar Formation
It is Our Intent to Conduct a Prospective Randomized Controlled Trial Examining the Use of Histoacryl© in the Closure of Surgical Incisions in Comparison to Subcuticular Suture and to Dermabond©.
1 other identifier
observational
21
1 country
1
Brief Summary
The use of tissue adhesives for the closure of surgical incisions is becoming increasingly common. Several publications exist purporting the equivalence of tissue adhesive to suture with regard to dehiscence, infection, and cosmesis. Two of the most frequently used adhesives are Histoacryl© and Dermabond©. Despite their popularity, only one study exists comparing the two. In this non-English study only small wounds in an exclusively pediatric population were studied (12). Operative time, cost, and objective measures of scar size were not examined. In the present study we aim to evaluate the relatively large surgical incisions resulting from breast reduction, mastopexy, panniculectomy, and abdominoplasty closed with either Histoacryl©, Dermabond©, or subcuticular suture. The primary aim is to investigate differences in time to wound closure. Secondary aims are to compare the three approaches with respect to cost, dehiscence, infection, scar size, and cosmesis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 29, 2009
CompletedFirst Posted
Study publicly available on registry
April 30, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2011
CompletedJune 21, 2012
June 1, 2012
1.8 years
April 29, 2009
June 19, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of Histoacryl© to Dermabond© is lacking. Investigation of Histoacryl© in direct comparison to Dermabond© as well as to suture.
1 year
Study Arms (2)
1-abdominal
half abdominal surgeries (20 patients out of 40)
2-breast
half breast surgeries (20 out of 40)
Interventions
surgical closure
Eligibility Criteria
1\) and 2): Reduction Mammoplasty or mastopexy patients: Patients who present to the plastic surgery clinic and are scheduled for breast procedures will be recruited and consented by a clinical studies co-ordinator. This will include patients undergoing a standard Wise pattern reduction mammoplasty (reduction and lift) or a standard Wise pattern mastopexy (lift only). See exclusion criteria below. 1\) and 2): Abdominoplasty or panniculectomy patients: Patients who present to the plastic surgery clinic and are scheduled for abdominal procedures will be recruited and consented by a clinical studies coordinator. See exclusion criteria below.
You may qualify if:
- Age: Younger than 21
- Gender: Females only. Given the nature of the procedures, as well as our clinical experience, we cannot anticipate recruiting enough male patients to be able to evaluate them as a subgroup. Since there may be differences in distributions of measures, to keep the groups more homogeneous we plan to recruit only females from the outset. Having either:
- Reduction Mammoplasty or mastopexy patients:
- Patients who present to the plastic surgery clinic and are scheduled for breast procedures will be recruited and consented by a clinical studies co-ordinator.
You may not qualify if:
- Abdominoplasty or panniculectomy patients:
- Though women of childbearing age will be allowed to participate in this study, no pregnant patients will be enrolled.
- Patients with any factors that may have an adverse effect on wound healing:
- previous hypertrophic scars or keloid
- known vitamin C deficiency
- known zinc deficiency
- smoking
- steroid use
- known connective tissue disorder
- hypoalbuminemia
- any factor not listed that the attending consultant seeing the patient feels would adversely effect wound healing.
- Patients who have a known sensitivity to adhesives
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
- Aesculap AGcollaborator
Study Sites (1)
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Galen Perdikis, M.D.
Mayo Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 29, 2009
First Posted
April 30, 2009
Study Start
April 1, 2009
Primary Completion
February 1, 2011
Study Completion
February 1, 2011
Last Updated
June 21, 2012
Record last verified: 2012-06